Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Journal of Clinical Endocrinology and Metabolism
Journal
Overview
Identity
Overview
Publication Venue For
Long-term change in physiological markers and cognitive performance in type 2 diabetes: The look ahead study
. 105.
2020
Race, ancestry, and Vitamin D metabolism: The multi-ethnic study of atherosclerosis
. 105.
2020
Screening for androgen excess in women: accuracy of self-reported excess body hair growth and menstrual dysfunction
. 105.
2020
Osteosarcopenia in Reproductive-Aged Women with Polycystic Ovary Syndrome: A Multicenter Case-Control Study
. 105:e3400-e3414.
2020
Letter to the Editor: "Distribution of Body Hair in Young Australian Women and Associations with Serum Androgen Concentrations"
. 105.
2020
Adipocyte insulin resistance in PCOS: Relationship with GLUT-4 expression and whole-body glucose disposal and β-cell function
. 105.
2020
Biomarkers and noncalcified coronary artery plaque progression in older men treated with testosterone
. 105.
2020
Prostate-Specific Antigen Levels during Testosterone Treatment of Hypogonadal Older Men: Data from a Controlled Trial
. 104:6238-6246.
2019
Improving Long-Term Outcomes of Youth with Lipid Abnormalities - Expanding the Role of Pediatric Endocrinologists
. 104:4421-4426.
2019
JC viruria is associated with reduced risk of diabetic kidney disease
. 104:2286-2294.
2019
Female Pattern Hair Loss and Androgen Excess: A Report from the Multidisciplinary Androgen Excess and PCOS Committee
. 104:2875-2891.
2019
The effect of testosterone on cardiovascular biomarkers in the testosterone trials
. 103:681-688.
2018
ACTIVExtend: 24 Months of alendronate after 18 months of abaloparatide or placebo for postmenopausal osteoporosis
. 103:2949-2957.
2018
Letter to the Editor: "Type B Insulin Resistance Masquerading as Ovarian Hyperthecosis"
. 102:3865-3866.
2017
The relationship between the score on a simple measure of cognitive function and incident CVD in people with diabetes: A post hoc epidemiological analysis from the accord-mind study
. 102:3218-3225.
2017
No increase in fractures after stopping hormone therapy: Results from the women's health initiative
. 102:302-308.
2017
Perspectives on polycystic ovary syndrome: Is polycystic ovary syndrome research underfunded?
. 102:4421-4427.
2017
Testosterone treatment and sexual function in older men with low testosterone levels
. 101:3096-3104.
2016
Erratum: Associations of total and undercarboxylated osteocalcin with peripheral and hepatic insulin sensitivity and B cell function in overweight adults (J Clin Endocrinol (2013) 98:7 (E1173-E1180) doi: 10.1210/jc.2013-1203)
. 101:2265.
2016
Prostate-specific membrane antigen is a potential antiangiogenic target in adrenocortical carcinoma
. 101:981-987.
2016
Vitamin D supplementation modulates t cell-mediated immunity in humans: Results from a randomized control trial
. 101:533-538.
2016
Bone mineral density as a predictor of subsequent wrist fractures: Findings from the women's health initiative study
. 100:4315-4324.
2015
Impact of phosphorus-based food additives on bone and mineral metabolism
. 100:4264-4271.
2015
Development of a weighted cardiometabolic disease staging (CMDS) system for the prediction of future diabetes
. 100:3871-3877.
2015
Association of sex hormones with sexual function, vitality, and physical function of symptomatic older men with low testosterone levels at baseline in the testosterone trials
. 100:1146-1155.
2015
Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genomewide association studies of chinese individuals
. 100:E182-E186.
2015
Letter to the editor re: Casarini and Brigante, 2014, from Azziz R., et al
. 100.
2015
Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW)
. 99:817-826.
2014
Insulin resistance indices are inversely associated with vitamin D binding protein concentrations
. 99:178-183.
2014
Polycystic ovary syndrome: What's in a name?
. 99:1142-1145.
2014
The expression of the miR-25/93/106b family of micro-RNAs in the adipose tissue of women with polycystic ovary syndrome
. 99:E2754-E2761.
2014
α-Internexin: A novel biomarker for pancreatic neuroendocrine tumor aggressiveness
. 99.
2014
The severity of menstrual dysfunction as a predictor of insulin resistance in pcos
. 98.
2013
Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome
. 98.
2013
Effects of endogenous androgens and abdominal fat distribution on the interrelationship between insulin and non-insulin-mediated glucose uptake in females
. 98:1541-1548.
2013
Update on treatment strategies for obesity
. 98:1299-1306.
2013
20S-hydroxyvitamin D
3
, noncalcemic product of CYP11A1 action on vitamin D
3
, exhibits potent antifibrogenic activity in vivo
. 98.
2013
Associations of Total and Undercarboxylated Osteocalcin with Peripheral and Hepatic Insulin Sensitivity and β-Cell Function in Overweight Adults
. 98.
2013
Serum 25-hydroxyvitamin D response to vitamin D
3
supplementation 50,000 IU monthly in youth with HIV-1 infection
. 97:4004-4013.
2012
Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility
. 97.
2012
Skeletal muscle lipid peroxidation and insulin resistance in humans
. 97.
2012
Association of intact parathyroid hormone levels with subsequent hip BMD loss: The Osteoporotic Fractures in Men (MrOS) study
. 97:1937-1944.
2012
Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome
. 97.
2012
Progesterone receptor-A and -B have opposite effects on proinflammatory gene expression in human myometrial cells: Implications for progesterone actions in human pregnancy and parturition
. 97.
2012
Relationship between MRI-measured bone marrow adipose tissue and hip and spine bone mineral density in African-American and Caucasian participants: The CARDIA study
. 97:1337-1346.
2012
Adolescent diet and metabolic syndrome in young women: Results of the Dietary Intervention Study in Children (DISC) follow-up study
. 96.
2011
Type 1 hyperlipoproteinemia and recurrent acute pancreatitis due to lipoprotein lipase antibody in a young girl with Sjögren's syndrome
. 96:3302-3307.
2011
Cardiac natriuretic peptides, obesity, and insulin resistance: Evidence from two community-based studies
. 96:3242-3249.
2011
Lower uncarboxylated osteocalcin concentrations in children with prediabetes is associated with β-cell function
. 96.
2011
Adiposity, inflammation, and risk for death in black and white men and women in the United States: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study
. 96:1805-1814.
2011
Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome
. 96.
2011
Dietary methionine restriction increases fat oxidation in obese adults with metabolic syndrome
. 96.
2011
Higher maternal gestational glucose concentration is associated with lower offspring insulin sensitivity and altered β-cell function
. 96.
2011
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An endocrine society clinical practice guideline (The Journal of Clinical Endocrinology & Metabolism (2010) 95 (4133-4160))
. 95:5137.
2010
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An Endocrine Society clinical practice guideline
. 95:4133-4160.
2010
DHEA-S levels and cardiovascular disease mortality in postmenopausal women: Results from the National Institutes of Health - National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Women's Ischemia Syndrome Evaluation (WISE)
. 95:4985-4992.
2010
Postmenopausal hormone therapy: An endocrine society scientific statement
. 95:s1-s66.
2010
Prospective association of serum androgens and sex hormone-binding globulin with subclinical cardiovascular disease in young adult women: The "coronary artery risk development in young adults" women's study
. 95:4424-4431.
2010
Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: Role of tumor necrosis factor-α
. 95:935-942.
2010
Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men
. 95:4625-4634.
2010
The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: A report from the los angeles atherosclerosis study
. 95:4432-4440.
2010
Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome
. 94:3282-3288.
2009
Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using
41
Ca methodology
. 94:3798-3805.
2009
Effect of dietary adherence with or without exercise on weight loss: A mechanistic approach to a global problem
. 94:1602-1607.
2009
Homocysteine levels and risk of hip Fracture in postmenopausal women
. 94:1207-1213.
2009
Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17β-hydroxysteroid dehydrogenase gene
. 94:5034-5038.
2009
Loss of rap1GAP in papillary thyroid cancer
. 94:1026-1032.
2009
Neuropsychological features in primary hyperparathyroidism: A prospective study
. 94:1951-1958.
2009
Prediction of changes in bone mineral density in postmenopausal women treated with once-weekly bisphosphonates
. 94:1097-1103.
2009
Serum 25-hydroxyvitamin D levels and rate of hip bone loss in older men
. 94:2773-2780.
2009
Threshold for effects of vitamin D deficiency on glucose metabolism in obese female African-American adolescents
. 94:3200-3206.
2009
Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: Comparative efficacy of ergocalciferol, cholecalciferol, and UV light
. 94:2037-2043.
2009
Vitamin D deficiency in older men
. 94:1214-1222.
2009
Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome
. 93:2909-2912.
2008
Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome
. 93:1939-1945.
2008
Associations among insulin, estrogen, and fat mass gain over the pubertal transition in African-American and european-american girls
. 93:2610-2615.
2008
Associations of serum sex hormone-binding globulin and sex hormone concentrations with hip fracture risk in postmenopausal women
. 93:1796-1803.
2008
Changes over 14 years in androgenicity and body mass index in a biracial cohort of reproductive-age women
. 93:2158-2165.
2008
Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate
. 93:3785-3793.
2008
Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage
. 93:809-814.
2008
Impact of obesity on the risk for polycystic ovary syndrome
. 93:162-168.
2008
Longitudinal analysis of the insulin-like growth factor system in African-American and European American children and adolescents
. 93:4917-4923.
2008
Nonreplication of the type 5 17β-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome
. 93:300-303.
2008
Pharmacokinetics and pharmacodynamic effects of an oral ghrelin agonist in healthy subjects (Journal of Clinical Endocrinology and Metabolism 92, (1814-1820))
. 93:1082.
2008
Polycystic ovary syndrome is a family affair
. 93:1579-1581.
2008
Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: Results from the National Institutes of Health - National Heart, Lung, and Blood Institute sponsored women's ischemia syndrome evaluation
. 93:1276-1284.
2008
Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease
. 93:4268-4275.
2008
Relationship of fat distribution with adipokines in human immunodeficiency virus infection
. 93:216-224.
2008
Three novel missense mutations within the LHX4 gene are associated with variable pituitary hormone deficiencies
. 93:1062-1071.
2008
Thyroid hormones directly alter human hair follicle functions: Anagen prolongation and stimulation of both hair matrix keratinocyte proliferation and hair pigmentation
. 93:4381-4388.
2008
Brief report: The age-associated decline of androgens in reproductive age and menopausal black and white women
. 92:4730-4733.
2007
Four novel mutations of the LHX3 gene cause combined pituitary hormone deficiencies with or without limited neck rotation
. 92:1909-1919.
2007
Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome
. 92:2659-2664.
2007
Pharmacokinetics and pharmacodynamic effects of an oral ghrelin agonist in healthy subjects
. 92:1814-1820.
2007
Position statement: Utility, limitations, and pitfalls in measuring testosterone: An endocrine society position statement
. 92:405-413.
2007
Soy isoflavones do not affect bone resorption in postmenopausal women: A dose-response study using a novel approach with
41
Ca
. 92:577-582.
2007
Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years
. 91:2631-2637.
2006
Phytoestrogens and lipoproteins in women
. 91:2209-2213.
2006
A mutant signal transducer and activator of transcription 5b, associated with growth hormone insensitivity and insulin-like growth factor-I deficiency, cannot function as a signal transducer or transcription factor
. 91:1526-1534.
2006
Degree of facial and body terminal hair growth in unselected black and white women: Toward a populational definition of hirsutism
. 91:1345-1350.
2006
Editorial: Uncoupling protein 3 and human metabolism
. 91:1226-1228.
2006
Diagnosis of polycystic ovarian syndrome: The Rotterdam criteria are premature
. 91:781-785.
2006
Position statement: Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An androgen excess society guideline
. 91:4237-4245.
2006
Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome
. 91:48-53.
2006
Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia
. 91:3451-3456.
2006
Variants in the 5α-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women
. 91:4085-4091.
2006
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: Results of a 6-month study
. 90:6072-6076.
2005
Effect of insulin on plasma vascular endothelial growth factor in children with new-onset diabetes
. 90:4920-4923.
2005
Health care-related economic burden of the polycystic ovary syndrome during the reproductive life Span
. 90:4650-4658.
2005
Resistin stimulation of 17α-hydroxylase activity in ovarian theca cells in Vitro: Relevance to polycystic ovary syndrome
. 90:4852-4857.
2005
Effects of aging on cytochrome B5 expression in the human adrenal gland
. 90:4357-4361.
2005
Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling
. 90:4350-4356.
2005
Voluntary weight reduction in older men increases hip bone loss: The osteoporotic fractures in men study
. 90:1998-2004.
2005
Association of the intestinal fatty acid-binding protein Ala
54
Thr polymorphism and abdominal adipose tissue in African-American and Caucasian women
. 90:1196-1201.
2005
Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome
. 90:66-71.
2005
Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome
. 89:5558-5562.
2004
Diet, insulin resistance, and obesity: Zoning in on data for Atkins dieters living in South Beach
. 89:4197-4205.
2004
The prevalence and features of the polycystic ovary syndrome in an unselected population
. 89:2745-2749.
2004
Hormones & you: patient information page. Hormones and obesity.
. 89.
2004
Androgen Excess in Women: Experience with over 1000 Consecutive Patients
. 89:453-462.
2004
Minimal Response of Circulating Lipids in Women with Polycystic Ovary Syndrome to Improvement in Insulin Sensitivity with Troglitazone
. 88:5137-5144.
2003
Relationship between serum leptin concentration and low-density muscle in postmenopausal women
. 88:1157-1161.
2003
Influence of family history of type 2 diabetes on insulin sensitivity in prepubertal children
. 88:192-195.
2003
Editorial: Polycystic ovary syndrome, insulin resistance, and molecular defects of insulin signaling
. 87:4085-4087.
2002
Contribution of insulin secretion and clearance to glucose-induced insulin concentration in african-american and caucasian children.
. 87:2218-2224.
2002
Contribution of insulin secretion and clearance to glucose-induced insulin concentration in African-American and Caucasian children
. 87:2218-2224.
2002
Troglitazone use in polycystic ovary syndrome [4]
. 86:5090-5091.
2001
Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: implications regarding defects in vesicle trafficking.
. 86:5450-5456.
2001
Adrenocortical secretion of dehydroepiandrosterone in healthy women: Highly variable response to adrenocorticotropin
. 86:2513-2517.
2001
Adrenocortical secretion of dehydroepiandrosterone in healthy women: highly variable response to adrenocorticotropin.
. 86:2513-2517.
2001
Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial
. 86:1626-1632.
2001
Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial.
. 86:1626-1632.
2001
Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: Implications regarding defects in vesicle trafficking
. 86:5450-5456.
2001
Weight loss is not associated hyperleptinemia in humans pancreatic cancer
. 86:162-166.
2001
Associations among oral estrogen use, free testosterone concentration, and lean body mass among postmenopausal women
. 85:4476-4480.
2000
Comment on extrapituitary parasellar macroadenoma in cushing's disease [1]
. 85:2082.
2000
Effects of aging on adrenal function in the human: Responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women
. 85:48-54.
2000
Leptin in postmenopausal women: Influence of hormone therapy, insulin, and fat distribution
. 85:1770-1775.
2000
The skin produces urocortin
. 85:815-823.
2000
Comment on extrapituitary parasellar macroadenoma in Cushing's disease.
. 85:2082.
2000
Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution.
. 85:1770-1775.
2000
Liquid chromatography-mass spectrometry detection of corticotropin-releasing hormone and proopiomelanocortin-derived peptides in human skin
. 85:3582-3588.
2000
Impact of architectural disruption on adrenocortical steroidogenesis in vitro.
. 84:1017-1021.
1999
Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
. 84:946-950.
1999
Cerebrospinal fluid and plasma leptin measurements: Covariability with dopamine and cortisol in fasting humans
. 84:3579-3585.
1999
Hypertension in women
. 84:1862-1866.
1999
Impact of architectural disruption on adrenocortical steroidogenesis in vitro
. 84:1017-1021.
1999
Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level
. 84:946-950.
1999
Adrenal androgen excess in the polycystic ovary syndrome: Sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis
. 83:2317-2323.
1998
Prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States: A prospective study
. 83:3078-3082.
1998
Characterization of corticotropin-releasing hormone (CRH) in human skin
. 83:1020-1024.
1998
Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS)
. 83:1976-1987.
1998
The effect of 17β-estradiol on adrenocortical sensitivity, responsiveness, and steroidogenesis in postmenopausal women
. 83:519-524.
1998
Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.
. 83:3078-3082.
1998
Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
. 83:2317-2323.
1998
Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS).
. 83:1976-1987.
1998
Androgen response to hypothalamic-pituitary-adrenal stimulation with naloxone in women with myotonic muscular dystrophy
. 83:3219-3224.
1998
Serum leptin and energy expenditure in children.
. 82:4149-4153.
1997
Effects of gender, ethnicity, body composition, and fat distribution on serum leptin concentrations in children
. 82:2148-2152.
1997
Effects of gender, ethnicity, body composition, and fat distribution on serum leptin concentrations in children.
. 82:2148-2152.
1997
The metabolic significance of leptin in humans: Gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure
. 82:1293-1300.
1997
The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure.
. 82:1293-1300.
1997
Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism
. 82:479-485.
1997
Cloning and expression of the glucocorticoid receptor from the squirrel monkey (Saimiri boliviensis boliviensis), a glucocorticoid-resistant primate
. 82:465-472.
1997
Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism.
. 82:479-485.
1997
Cloning and expression of the glucocorticoid receptor from the squirrel monkey (Saimiri boliviensis boliviensis), a glucocorticoid-resistant primate.
. 82:465-472.
1997
Aging alters zonation in the adrenal cortex of men
. 82:3898-3901.
1997
Serum leptin and energy expenditure in children
. 82:4149-4153.
1997
Role of the β
3
-adrenergic receptor locus in obesity and noninsulin- dependent diabetes among members of Caucasian families with a diabetic sibling pair
. 81:4422-4427.
1996
ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin
. 81:2746-2749.
1996
ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin.
. 81:2746-2749.
1996
Mechanisms of enhanced insulin sensitivity in endurance-trained athletes: effects on blood flow and differential expression of GLUT 4 in skeletal muscles.
. 80:2437-2446.
1995
Immunocytochemical analyses of dehydroepiandrosterone sulfotransferase in cultured human fetal adrenal cells.
. 80:1027-1031.
1995
Adrenal androgen excess in women: Lack of a role for 17-hydroxylase and 17,20-lyase dysregulation
. 80:400-405.
1995
Erratum: Immunocytochemical analyses of dehydroepiandrosterone sulfotransferase in cultured human fetal adrenal cells (Journal of Clinical Endocrinology and Metabolism (1995) 80 (1027-1031))
. 80:1971.
1995
Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children
. 80:172-178.
1995
Immunocytochemical analyses of dehydroepiandrosterone sulfotransferase in cultured human fetal adrenal cells
. 80:1027-1031.
1995
Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: A prospective randomized study
. 80:3406-3411.
1995
Mechanisms of enhanced insulin sensitivity in endurance-trained athletes: Effects on blood flow and differential expression of GLUT 4 in skeletal muscles
. 80:2437-2446.
1995
Clinical review 56: nonclassic adrenal hyperplasia: Current concepts
. 78:810-815.
1994
Immunohistochemical localization of dehydroepiandrosterone sulfotransferase in human fetal tissues
. 78:234-236.
1994
Regulation of extragonadal insulin-like growth factor-binding protein-3 by testosterone in oophorectomized women
. 79:1747-1751.
1994
Insulin-responsive human adipocytes express two glucose transporter isoforms and target them to different vesicles.
. 77:286-289.
1993
Insulin-responsive human adipocytes express two glucose transporter isoforms and target them to different vesicles
. 77:286-289.
1993
Adrenocorticotropin interferes with transforming growth factor-β-induced growth inhibition of neocortical cells from the human fetal adrenal gland
. 75:1519-1521.
1992
Abnormalities of 21-hydroxylase gene ratio and adrenal steroidogenesis in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to acute adrenal stimulation
. 73:1327-1331.
1991
The effects of prolonged hypertestosteronemia on adrenocortical biosynthesis in oophorectomized women
. 72:1025-1030.
1991
Acute adrenocorticotropin-(1–24) (ACTH) adrenal stimulation in eumenorrheic women: Reproducibility and effect of acth dose, subject weight, and sampling time
. 70:1273-1279.
1990
Changes in Endocrine Function after Adrenal Medullary Transplantation to the Central Nervous System
. 71:773-776.
1990
On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism
. 70:431-436.
1990
21-Hydroxylase Deficiency in Female Hyperandrogenism: Screening and Diagnosis
. 69:577-584.
1989
CV 205–502 treatment of hyperprolactinemia
. 68:336-339.
1989
Methionine-enkephalin and thyrotropin-stimulating hormone are intimately related in the human anterior pituitary
. 66:804-810.
1988
The effects of dexamethasone and anencephaly on newborn serum levels of apolipoprotein A-1.
. 65:1098-1101.
1987
In vivo immunoreactive adrenocorticotropin (ACTH) production by human mononuclear leukocytes from normal and ACTH-Deficient individuals
. 64:98-105.
1987
Bromocriptine as primary therapy for prolactin-secreting macroadenomas: Results of a prospective multicenter study
. 60:698-705.
1985
Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus
. 60:559-568.
1985
Umbilical Cord Plasma Levels of Dehydroepiandrosterone Sulfate during Human Gestation
. 54:1216-1220.
1982
Diurnal patterns and regulation of cortisol secretion in pregnancy
. 51:466-472.
1980
Plasma angiotensin converting enzyme activity in mother and fetus
. 46:434-439.
1978
Effects of ph and enzyme inhibitors on apparent generation of angiotensin i in human plasma
. 39:965-968.
1974
Identity
International Standard Serial Number (issn)
0021-972X
Electronic International Standard Serial Number (eissn)
0021-972X
1945-7197